The atomic force microscope (AFM) uses a sharp micron-scale tip to scan and amplify surface features, providing exceptionally detailed topographical information with magnification on the order of ×10 6 . This instrument is used extensively for quality control in the computer and semiconductor industries and is becoming a progressively more important tool in the biological sciences. Advantages of the AFM for biological application include the ability to obtain information in a direct, label-free manner and the ability to image in solution, providing real-time data acquisition under physiologically relevant conditions. A novel application of the AFM currently under development combines its surface profiling capabilities with fixed immunocapture using antibodies immobilized in a nanoarray format. This provides a distinctive platform for direct, label-free detection and characterization of viral particles and other pathogens. (Journal of Biomolecular Screening 2004:491-497) 
INTRODUCTION
T HE CURRENT PUSH TO DEVELOP label-free methods for measuring bioaffinity interactions is driven by the needs of an evolving field. The wealth of potential new targets provided by the genomics revolution has emphasized the need for rapid and robust platforms for diagnostic, drug development, and environmental testing purposes. Label-free readout methods provide obvious advantages over fluorescent and other indirect reporter-based techniques. For example, readout methods that employ optically active or radioactive labeling molecules are expensive, are timeconsuming, and require multiple wash steps. The labeling process may alter the tertiary structure of the protein and possibly interfere with the bioaffinity interaction under study. In addition, problems such as label stability and photo bleaching encountered with fluorescent reporters may interfere with data collection and analysis. In this article, we introduce the atomic force microscope (AFM), coupled with protein-arraying technology, as an analytical system for label-free pathogen detection and analysis of protein bioaffinity in-teractions. The AFM provides high-resolution topographical imaging, requires no signal amplification and minimal sample processing, and can be performed from exceedingly small sample volumes. These assets position the AFM as an ideal tool for development as a high-throughput, reporter-free, molecular analysis platform technology.
FUNDAMENTALS OF AFM OPERATION
The AFM is the most commonly used member of the family of scanning probe microscopes (SPMs), developed by Gerd Binnig and colleagues during a collaboration between IBM and Stanford in the early 1980s. 1, 2 An example of a typical AFM is shown in Figure 1A . The basic concept of AFM operation involves the movement of a sharp, nanometer-scale tip in a raster pattern over a surface. This process is analogous to a phonograph needle reading the surface of groves and peaks of a vinyl record but in an extremely miniaturized format. The tip, generally microfabricated out of silicon or silicon nitride, is attached to a flexible cantilever ( Fig. 1B) . As surface features are encountered by the AFM tip, the deflection of the cantilever is recorded and used to create a force-based map of the sample (see Fig. 1A ). In the simplest form of AFM imaging, the interaction between the tip and the surface measures the minute adhesive and repulsive forces as the tip interacts with molecules on the surface to create an extremely precise relief map of the sample being scanned. The movement of the cantilever is controlled in x, y, and z by piezoelectric crystals, and a laser-based optical system is used to track the deflection of the cantilever with respect to the sample surface. 3 As the tip encounters surface features, tiny distur-bances in z cause the cantilever to bend. This movement is amplified by a laser beam focused on the backside of the cantilever that reflects onto a split photodiode, tracing the position of the cantilever.
The 2 most common forms of AFM operation are contact and tapping modes. In contact imaging, sample topography can be measured using constant-height or constant-force settings. In constant-height mode, the distance between the tip and the surface remains fixed during scanning, but the force between the tip and surface changes as the tip encounters surface features. Deflections in the position of the cantilever are used to create an image of the surface. In constant-force mode, the tip remains in contact with the sample using a known applied vertical force as the cantilever scans over the surface. Deflection of the cantilever signals a change in the voltage sent to the z piezo that is adjusted to maintain a constant interaction force between the tip and surface. This voltage sent to the z piezo is converted into height data to create the image.
In tapping mode, also known as intermittent-contact or dynamic force microscopy, the cantilever is oscillated at or near its resonance frequency. The tip-surface interaction energy, which is related to force, is controlled by a feedback mechanism that monitors the amplitude of oscillation. 4 The tip delicately "taps" the sample thousands of times per second as the tip raster scans. Changes in feedback that are applied to the z piezo are used to control the changes in amplitude that occur when the tip encounters surface features. This feedback voltage can be used to construct a topographical map of the surface. This type of imaging greatly reduces lateral and shear forces that can occur during the contact mode and damage soft surfaces such as biological molecules. The tapping mode is therefore the method of use favored in many biological applications.
The AFM is capable of approximately 2 nanometers (nm) lateral resolution and less than 1 nm vertical resolution. This level of discrimination allows the AFM to detect changes in topography in the Angstrom (10 -10 meter) range. Images captured with the AFM provide detailed 3-D information about surface qualities of both static and biological surfaces, and the instrument finds extensive use in the examination of materials and quality control in the semiconductor, aeronautics, electronics, telecommunications, and automotive industries. AFM image data can be captured from dry surfaces under ambient temperature or in liquid, allowing the option of real-time data collection under physiologically relevant conditions. [5] [6] [7] In summary, the AFM directly "sees" molecules bound to a surface by virtue of a change in local topography. This ability allows the AFM to distinguish between a single monolayer of proteins bound to a surface and multiple layers that result from an interaction between members of an affinity pair. The Z sensitivity of the AFM is sufficient to detect height changes when an antibody binds a surface-bound antigen or, vice versa, when a surface-bound antigen captures a soluble antigen. [8] [9] [10] Figure 2 shows an example of an AFM immunoassay of this type, with a surface-bound antigen before and after incubation with a specific antibody. In this experiment, the change in height is on the order of 1 to 3 nm and provides a large change in signal.
High-resolution topographical imaging is only one of the many surface analysis capabilities of the AFM. It is also widely used in force measurement applications. For example, a variation of contact AFM, known as lateral force microscopy (LFM), measures the twisting, or torque, of the cantilever as it scans a surface. 11 Information on frictional properties of a surface can be obtained from this mode of imaging. Another method, known as force-distance mode, directly measures interaction forces within and between molecules. This method generates "force curves," which measure the tip deflection during approach-retraction cycles as the tip is brought toward and pulled away from a surface location. This is a powerful method for obtaining detailed information about molecular conformations that is being increasingly employed. 12 Modification of the tip by coating with biological molecules, such as a protein ligands or receptors, allows a specific interaction between an affinity duo, and accurate measurements of intermolecular binding constants have been recorded. 13, 14 Single antibody-antigen recognition events can be detected using this approach. [15] [16] [17] These multiple capabilities of the AFM, in combination with the potential for single-molecule resolution, have allowed the AFM to find a niche in biological applications and has been used to acquire detailed surface structure information from both fixed and living cells, microorganisms and viruses. [18] [19] [20] Dynamics of cell movement, force studies of cell adhesion, and other processes can be studied in real time using the AFM. 21, 22 
VIRUS DETECTION
Historically, the electron microscope (EM) has played a key role in the discovery and structural characterization of new viral isolates. 23, 24 Today, it is used mainly as a research tool and not in mainstream routine diagnoses because it is not suited for highthroughput analyses. It does, however, play a role in the clinical or epidemiological setting when critical situations require a rapid diagnosis, as it is currently the only method available that allows morphological identification by direct visualization of intact virus particles. In these situations, EM allows identification of novel or unsuspected agents and is vital, especially in light of recent bioterrorist threats. For routine virus detection and disease monitoring, available methods rely almost exclusively on PCR or enzyme-linked immunosorbent assay (ELISA) to identify and measure levels of viral DNA or RNA in the case of PCR or viral proteins and antiviral antibodies in the case of ELISA. [25] [26] [27] [28] These methods provide high throughput and high specificity but are expensive. Also, as they do not measure intact virus particles, they are indirect measures of viral load and may not be the most desirable method for use in situations where direct monitoring of viral load is significant for patient care. For example, measuring viral load is one important aspect of disease monitoring in HIV-infected individuals, and this information is used by the physician to determine drug therapies and treat- ment schedules. 29, 30 Also, in conditions where viral latency has been established, the ability to directly monitor recurrences through the measurement of intact viral particles would be a great asset in the clinical setting.
Label-Free Protein and Pathogen Detection

THE USE OF THE AFM IN VIRUS CHARACTERIZATION AND DETECTION STRATEGIES
The AFM is progressively finding use in structural virology. In 1992, Kolbe and colleagues were the first to use the AFM to image T4 bacteriophage, and since this time, many investigators have used AFM for studies of viral structure. 31, 32 The AFM does not typically match EM or X-ray crystallography in terms of fine resolution. However, it is a nondestructive method that offers the ability to image specimens under liquid. This allows the study of intact virus particles, without the distortion caused by fixation and staining, and has facilitated analysis of virus-host interactions in real time. Examples of morphological delineation of various virus particles using the AFM are shown in Figure 3 .
We have coupled protein-arraying technology with atomic force microscopy readout to produce label-free, multiplexed, chipbased detection systems for virus identification. Specificity of antibody capture, coupled with the AFM's accurate height measurements, permits acquisition of morphological information about viral particles to facilitate their identification. 33, 34 There are 3 essential components required of a system that uses AFM for label-free analysis: a tool for making ultraminiaturized bioarrays, chips that are compatible with AFM imaging, and an AFM that has been optimized for the application. For AFM to be a viable method of biomolecular analysis, the domains to be studied must fit within the typical 100 × 100-µm scan field of most atomic force microscopes. This is approximately the size of a single microarray spot, therefore necessitating further advances in array miniaturization. Reduction of protein domains to the micron and submicron scale required the development of a novel system, embodied in an instrument called a NanoArrayer ™ (see Fig. 4 ). This device uses a mechanical deposition process similar to a standard pin tool microarrayer. Custom microfabricated surface patterning tools (SPTs) transfer attoliter and femtoliter volumes of biomolecules onto chip surfaces. 35 Surface contact forces are monitored to facilitate the deposition process. A high-resolution X-Y stage provides the spatial precision required for generation of ultraminiaturized domains. An environmental chamber and integrated computer control system regulate the humidity to preserve biomolecule activity and ensure consistent spotting.
A major component of this virus detection system is the miniaturized chip surface that can be arrayed with highly specific capture probes. Capture probes can either consist of antibodies to specific antigens, antigens used to detect antibodies (such as the detection of HIV antibodies in blood), or aptamers, which are nucleic acids that can be used like antibodies. 36 The capture molecules are spotted on chip surfaces in domains that are only a few microns to several hundred nanometers in diameter. Because of their small size, thousands of capture probes can be packaged in an ultra-miniaturized chip format. 37 Identification of binding events by virtue of height changes detected with an AFM requires a chip surface with exceptional flatness, as well as immobilization of the sample onto this surface. Any surface anomalies or contamination will interfere with the postacquisition image analysis. Despite their advantages of high binding capacity and preservation of protein conformation, 3-D Highly polished silicon wafers are often used as the starting material for AFM biochip construction. These wafers can be patterned as desired using photolithography and standard wet etching techniques. These indexed pads are helpful for locating or returning to a particular nanoarray. Ion beam sputtering of a thin gold film onto the polished silicon chips facilitates the formation of an alkanethiol self-assembling monolayer (SAM) with a defined amine-reactive moiety. 38 This succinimide SAM allows for the direct covalent coupling of antibodies, aptamers, or other aminefunctionalized molecules deposited with the NanoArrayer ™ .
Our studies show that the nanoarray-based antibody capture of larger entities, such as a virus, results in a height change on the order of 30 to 300 nm. Figure 5 shows AFM scans of a ViriChip cross-reactivity assay done on the macro-scale by immobilization of 3 different antivirus antibodies onto a separate 4-mm 2 goldsputtered silicon substrate, followed by incubation with each of the 3 different viruses. The number of bound virus particles for each antibody is displayed as a bar graph in the bottom row. The data are quantified by simply counting the number of virus particles as a function of time and concentration. The panels in the left column show that anti-fd antibodies were competent to capture fd phage but did not capture canine parvovirus (CPV) or Coxsackievirus B3 Nancy (CB3) particles. Likewise, the panels in the middle show that anti-CPV antibodies only bound CPV, whereas the right panels show that anti-CB3 antibodies only captured CB3 particles. Thus, virtually no cross-reactivity occurs, and virus particles are only detected on the surface where specific capture antibodies are immobilized. On average, the variation in signal on a single chip is less than 5%, and between chips, it is approximately 5% to 8%.
This technology does not require extensive sample preparation. In most cases, a simple dilution of the starting material into a biological buffer is the only necessary preparation. This is a major advance over most genomic and proteomic detection systems, which must destroy the pathogens and extract either nucleic acid or protein from the sample to analyze. As a consequence, we can directly determine the number of pathogen particles in a sample, a measurement that is critical in determining the magnitude of the hazardous threat of the biological agent. In contrast, DNA detection systems and ELISAs must extrapolate the analyte levels they detect to the number of pathogen particles in a sample, and that estimation may or may not be accurate. This technique is at least 100fold more sensitive than direct ELISA methods using the same reagents, and performance time is approximately one-third that required to carry out an ELISA. Like other solid-phase assay systems, the sensitivity of label-free AFM detection of proteins and viruses is constrained by the affinity of the capture molecule for its target. Due to the nature of AFM, however, these assays may be miniaturized to the micron or submicron scale. When used in conjunction with microfluidics of the same scale, samples are placed in close proximity to the capture domains for more efficient harvesting of analyte. The result of these combined technological advances is a platform with equal or superior capture efficiencies for a wide variety of pathogens and proteins, as well as an amplification-free detection scheme with single-molecule resolution.
The final component of an AFM-based platform for label-free biomolecular analysis is the AFM itself. We are currently using commercially available research-grade instruments for this purpose. Such devices provide the operator with a wide variety of adjustments and options in an open architecture. For broader acceptance of this technology, however, the AFM will need to shed some of the extraneous features, replace the countless options with a simple user interface, and begin to adopt some standards (e.g., chip size) as it migrates from a research instrument to a clinical instrument. Adoption of the AFM as a biomolecular screening tool will , anti-CPV (middle column; canine parvovirus) and anti-CB3 (right column; Coxsackievirus B3 Nancy) antibodies were exposed to 1 µL of fd (10 10 pfu/mL; first row), 1 µL CPV (60 µg/mL; second row), or 1 µL CB3 virus (10 7 pfu/mL; third row). Following incubation with virus, the chips were rinsed with a stream of water, blown dry under argon gas, and imaged under ambient conditions by the tapping mode using a Dimensions 3100 from Digital Instruments/Veeco (Santa Barbara, CA) equipped with a silicon ultralever (TM Microscopes, now Veeco). Atomic force microscope (AFM) field size = 3 µm 2 , Z scale (dark to light) = 15 nm for the first row (fd) and 30 nm for rows 2 and 3. This figure was reprinted with permission from Elsevier, © 2003. 33 also depend on practical issues such as limitations on throughput and automation. Critics of AFM as a readout tool often point out mechanical complexity, tip contamination, slow scan speed, and instrument size as issues that must be addressed. Solutions to all of these problems have already been found and implemented, although they have yet to be combined into 1 simple benchtop device. Small, straightforward AFMs, such as the EasyScan E-AFM from Nanosurf AG (Switzerland), demonstrate that a quality instrument can come in a small package. Slow scan speeds are becoming a historical artifact as progress continues to be made in the area of fast-scan AFM. Shrinking cantilevers with integrated piezoelectric actuators and sensing mechanisms are enabling 10fold increases in scan speed. 39 Today's commercial atomic force microscopes operate with a single probe, which would be suitable for scanning an array of a few hundred capture domains from a single sample. Scaling up to a greater number of capture domains or analyzing a large number of distinct samples would require either scanning individual arrays in a serial fashion with a single probe or incorporating a parallel array of probes capable of scanning simultaneously. This latter concept of an array of individually actuated scanning probes has already been demonstrated by academic researchers, but it has not reached the commercial stage yet. Automation of atomic force microscopes for the semiconductor industry has advanced a great deal beyond most research-grade instruments. In fact, the once laborious task of tip replacement can now be accomplished without any user intervention. These automation concepts should be easily applied to a biological AFM platform.
